Kessing Svend Vedel, Flesner Per, Jensen Peter Koch
Glaucoma Clinic, Eye Department, Copenhagen University Hospital, Rigshospitalet, Denmark.
J Glaucoma. 2006 Apr;15(2):84-90. doi: 10.1097/00061198-200604000-00002.
Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy. This is related to a higher incidence of avascular, thin, cystic, translucent blebs, which may be caused by a toxic effect on conjunctival tissue. An MMC dose-response study was carried out focusing on bleb morphology and function.
In a retrospective, comparative case series study, 2 successive groups of patients with complicated glaucoma were compared 2 years after a special, minimally invasive, filtering procedure (intrastromal holmium laser keratostomy). Preoperative local subconjunctival injections of a fixed MMC dose (4 microg) were used in group A, and lower MMC doses, calculated individually (1 or 2 microg), were used in group B. Bleb vascularity and morphology were evaluated by masked grading of photomicrographs. Bleb function was evaluated by intraocular pressure (IOP).
Total bleb avascularity occurred in 63% of the blebs in group A and 0% in group B (P < 0.01). In eyes with IOP < or = 20 mmHg without medical treatment, the mean IOP was significantly lower in group 1 (8 vs 15 mm Hg, P < 0.002). A translucent cystic bleb without conjunctival stroma was observed in only 1 eye in group A. An optimal spongy stromal bleb was observed in all other eyes (96%) despite the different MMC doses. The numbers of complications in the 2 groups were nearly equal.
Bleb avascularity after 4 microg MMC could be avoided by the use of 1 or 2 microg MMC on the basis of preoperative prognosticators for failure, but at the expense of some of the IOP-lowering effect. This indicates that the therapeutic index (clinical safety margin) of MMC seems to be narrow. An MMC dose-response relation was not observed for the thin, cystic, and translucent bleb. The low incidence of this bleb (4%) indicates that the operative technique, apart from the vascularity, may be the most essential determinant of bleb morphology.
抗代谢药物,尤其是丝裂霉素C(MMC),会增加小梁切除术中晚期滤泡相关性眼内炎的发生率。这与无血管、薄、囊性、半透明滤泡的发生率较高有关,这可能是对结膜组织的毒性作用所致。开展了一项针对滤泡形态和功能的MMC剂量反应研究。
在一项回顾性、比较性病例系列研究中,对两组连续的复杂性青光眼患者在接受一种特殊的微创滤过手术(基质内钬激光角膜造口术)2年后进行比较。A组术前局部结膜下注射固定剂量的MMC(4微克),B组使用根据个体情况计算的较低MMC剂量(1或2微克)。通过对显微照片进行盲法分级来评估滤泡血管化和形态。通过眼压(IOP)评估滤泡功能。
A组63%的滤泡出现完全无血管,B组为0%(P < 0.01)。在未经药物治疗眼压≤20 mmHg的眼中,A组的平均眼压显著更低(8 vs 15 mmHg,P < 0.002)。A组仅1只眼观察到无结膜基质的半透明囊性滤泡。尽管MMC剂量不同,但在所有其他眼中(96%)均观察到了最佳的海绵状基质滤泡。两组的并发症数量几乎相等。
根据术前失败预测因素使用1或2微克MMC可避免4微克MMC后的滤泡无血管化,但会牺牲部分降眼压效果。这表明MMC的治疗指数(临床安全范围)似乎较窄。未观察到MMC剂量与薄、囊性和半透明滤泡之间的剂量反应关系。这种滤泡的低发生率(4%)表明,除血管化外,手术技术可能是滤泡形态的最重要决定因素。